相关实验视频

Updated: Jul 5, 2025

Generation of Human Microglia to Combine Them with Retinal Organoids for Improved Disease Modeling

Generation of Human Microglia to Combine Them with Retinal Organoids for Improved Disease Modeling

Published on: July 26, 2024

增强了来自视网膜母细胞瘤患者特异性iPSCs的微质中的先天反应

Jia Xu¹, Si-Jian Yu¹, Shuning Sun¹

¹Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

|January 23, 2024

概括

微质细胞 (眼睛的免疫细胞) 中的RB1缺乏会增强炎症反应,并有助于视网膜母细胞瘤 (Rb) 的发展. 这表明微质细胞在Rb进展中起着关键作用,并提供潜在的治疗点.

科学领域:

眼科医生眼科眼科
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

视网母细胞瘤 (Rb) 是最常见的眼睛癌症,与RB1基因缺陷有关.
视网膜免疫细胞微质细胞在Rb病变发生过程中至关重要.
在Rb的背景下,RB1在微质功能中的作用仍然不清楚.

研究的目的:

研究从干细胞中获得的人类微质中的RB1的功能.
确定RB1缺乏如何影响微质细胞和免疫反应.
评估RB1缺乏微质对视网膜有机体的影响.

主要方法:

从Rb患者衍生的诱导多能干细胞 (hiPSCs) 和胚胎干细胞 (hESCs) 中分化的微质细胞.
通过实时成像,免疫光学,RNA-seq,qRT-PCR,ELISA和与视网膜有机体共同培养来评估微质功能.
分析了RB1表达,细胞活动,细胞因子分泌和信号通路 (例如,MAPK).

主要成果:

RB1在微质中高度表达,主要在细胞核中.
缺乏RB1并没有改变微质特异性标志物或细胞化.
缺乏RB1的微质细胞在LPS刺激时显示出增强的先天性免疫反应,包括IL-6和TNF-α的升高.
与缺乏RB1的微质一起共同培养破坏了视网膜器官结构.

结论:

缺少RB1增强了微质的炎症反应,而不会影响细胞化.
缺少RB1的微质细胞有助于视网膜损伤,使它们与RB发育有关.
准微质功能是视网膜母细胞瘤的潜在治疗策略.

关键词:

RB1 RB1 是一个字符串.细胞因子细胞因子这是先天免疫力.微质细胞中的微质细胞视网膜母细胞瘤 (Retinoblastoma) 是一种

更多相关视频

Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders

Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders

Published on: September 6, 2024

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route

Published on: May 31, 2022

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...